All articles by Heena Singla

The poor allergy related drug availability in the Indian pharma market

Universally, drug availability is divided into 3 categories based on the novelty and level of risk as per the USFDA (Pacifici and Bain, 2018). Drug availability is a rising issue in the Indian pharmaceutical market. These drugs comprise of:

  • New drugs (drugs that were never been approved before).
  • Generics (copy of a branded drug).
  • Over the counter (OTC) drugs (can be purchased without a prescription).
Read more »

Understanding the pharmaceutical marketplace of India

In the global pharmaceutical marketplace, the Indian pharmaceutical industry is at 13th position, in terms of value and has the 3rd largest volume (Department of Commerce, 2017). Currently, pharmaceutical sales in India stand at USD 20 billion. It is envisaged to extend to 55 billion by 2020 with a compound annual growth rate (CAGR) of 15.92%. Indian pharmaceutical sector holds a key position in the global export market of pharmaceuticals. The US branded generic drugs are the major pharmaceutical drugs exported outside India. It comprises approximately 20% of the global generic drugs (Chandra, 2016).

Read more »

We are looking for candidates who have completed their master's degree or Ph.D. Click here to know more about our vacancies.